|
Tuesday, March 10 — 8:00 AM — CC BR B
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section B - BREAST
Chaired by: Sunil Lakani and Laura Collins
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
Molecular Analysis of Invasive Micropapillary Carcinoma of the Breast
(185)
N Gruel, V Raynal, P Freneaux, C Lucchesi, R Karkouche, G Pierron, V Fourchotte, Y Kirova, JY Pierga, X Sastre-Garau, B Sigal-Zafrani, S Roman-Roman, O Delattre, A Vincent-Salomon - INSERM U830, Paris, France; Institut Curie, Paris, France
|  Add |
| 8:15 |
The Relationship between Oncotype DX Recurrence Score, Clinicopathological Factors, and Molecular Classification in Breast Cancer
(311)
P Tang, J Wang, DG Hicks, X Wang, L Schiffhauer, M Shayne, A Huston, K Skinner, J Griggs, G Lyman - University of Rochester Medical Center, Rochester, NY; RTI Health Solution, Research Triangle Park, NC; University of Michigan Medical Center, Ann Arbor, MI; Duke University Medical Center, Durham, NC
| Add |
| 8:30 |
The Role of Sentinel Node Mapping in Patients with High Grade Ductal Carcinoma In-Situ Diagnosed by Needle Core Biopsies
(136)
LF Chiles, YM Brill, J Hinson, H Wright, P McGrath, LM Samayoa - University of Kentucky, Lexington, KY
| Add |
| 8:45 |
Detection of Occult Metastases in Sentinel Lymph Nodes: Comparison of a Limited Widely Spaced and a Comprehensive Narrowly Spaced Paraffin Block Sectioning Strategy
(230)
UP Le, K Weaver, SL Dupuis, T Ashikaga, DN Krag, S Harlow, DL Weaver - University of Vermont and Fletcher Allen Health Care, Burlington, VT
| Add |
| 9:00 |
Detection of Minimal Residual Disease in Blood and Bone Marrow in Early Breast Cancer
(221)
S Krishnamurthy, B Singh, J Reuben, A Lodhi, M Cristofanilli, A Lucci - MD Anderson Cancer Center, Houston, TX
| Add |
| 9:15 |
Comparative and Additive Sensitivities of Immunohistochemical Markers of Breast Cancer Using New Monoclonal Antibodies to GCDFP-15 and Mammaglobin
(290)
AJ Shaw, LC Goldstein, PL Kandalaft, HC Hwang, SJ Kussick, AM Gown - PhenoPath Laboratories, Seattle, WA; IMPRIS, Seattle, WA
| Add |
| 9:30 |
RECESS, EXHIBITS AND POSTER SESSION III
| |
| 11:00 |
The Effects of ASCO/CAP Guidelines on Her2/Neu Reporting: An Analysis of 662 Consecutive Breast Cancer Cases with Emphasis on IHC 2+ and 3+ Cases
(204)
PB Illei, C Griffin, H Nassar - The Johns Hopkins Medical Institutions, Baltimore, MD
| Add |
| 11:15 |
Making Sense of the Her-2/neu Immunohistochemistry Equivocal Category Post-SCO/CAP Guidelines
(151)
AM Dastane, S Bose - UCLA, Los Angeles, CA; Cedars-Sinai Medical Center, Los Angeles, CA
| Add |
| 11:30 |
Do Chromosome 17 Centromere Copy Numbers Predict Polysomy? A Fluorescence In Situ Hybridization and Microarray-Based CGH Analysis
(240)
C Marchio, MBK Lambros, P Gugliotta, LV Di Cartogno, C Botta, B Pasini, KK Shiu, A Mackay, K Fenwick, N Tamber, A Ashworth, A Sapino, JS Reis-Filho - ICR, London, United Kingdom; University of Turin, Turin, Italy
| Add |
| 11:45 |
HER2 Concordance between Central Laboratory Immunohistochemistry, FISH and Quantitative RT-PCR in Intergroup Trial E2197
(115)
FL Baehner, R Gray, B Childs, T Maddala, S Rowley, S Shak, NE Davidson, GW Sledge, LJ Goldstein, JA Sparano, S Badve - UCSF, San Francisco, CA; ECOG, Indianapolis, IN; Sanofi-aventis, Bridgewater, NJ; Genomic Health, Redwood City, CA
| Add |
|
|
